RxDoctor Payments Data

Ashwini Gade, MD

Family Medicine · Parker, CONPI 1619109972

Payments from drug & device makers

$199in general payments, 2019–2025

Across 12 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$61
  • Johnson & Johnson$54
  • Novo Nordisk$20
  • Avanir Pharmaceuticals, Inc.$20
  • Radius Health, Inc.$17
  • Acadia Pharmaceuticals Inc$16
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$199100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$199 in reported general payments places this provider in the 55th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$134,367
Medicare patients
320
Services billed
1,079

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate22$127,960
EliquisApixaban251$71,819
TrulicityDulaglutide31$26,015
XareltoRivaroxaban88$24,783
OzempicSemaglutide17$17,200
AbrysvoRsv Vacc, Pref A And Pref B/Pf50$16,652
XifaxanRifaximin11$16,389
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,139
ArexvyRsvpref3 Antigen/As01e/Pf34$10,152
CreonLipase/Protease/Amylase24$9,735
LinzessLinaclotide15$8,444
MyrbetriqMirabegron42$7,919
JardianceEmpagliflozin26$7,896
Incruse ElliptaUmeclidinium Bromide18$6,384
Xigduo XrDapaglifloz Propaned/Metformin21$6,102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$54$24,78388 claims
Novo NordiskOzempic$20$17,20017 claims
Astellas Pharma US IncMyrbetriq$61$7,91942 claims
NovartisEntresto$11$5,62818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Parker

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →